BMC Musculoskeletal Disorders

official impact factor 1.94
Search for
Advanced search
BMC Musculoskeletal Disorders
Tools
Share this article
Open Access Highly Access Email this article to a friend

S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]

Wadie I Najm*, Sibylle Reinsch, Fred Hoehler, Jerome S Tobis and Phillip W Harvey

BMC Musculoskeletal Disorders 2004, 5:6 doi:10.1186/1471-2474-5-6

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.